Compare OMCL & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMCL | ATRC |
|---|---|---|
| Founded | 1992 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2000 | 2005 |
| Metric | OMCL | ATRC |
|---|---|---|
| Price | $40.82 | $34.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $55.83 | $51.17 |
| AVG Volume (30 Days) | 691.4K | ★ 991.1K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $787,309,000.00 | $201,630,000.00 |
| Revenue This Year | $6.77 | $15.27 |
| Revenue Next Year | $5.22 | $12.21 |
| P/E Ratio | $159.44 | ★ N/A |
| Revenue Growth | 9.93 | ★ 15.40 |
| 52 Week Low | $28.09 | $25.36 |
| 52 Week High | $51.84 | $43.18 |
| Indicator | OMCL | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 58.67 |
| Support Level | $35.81 | $30.77 |
| Resistance Level | $45.72 | $34.38 |
| Average True Range (ATR) | 1.84 | 1.32 |
| MACD | -0.65 | -0.20 |
| Stochastic Oscillator | 21.22 | 43.63 |
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.